SCHEMBL4601375

SCHEMBL4601375

CCCN(C(=O)Oc1c(OCCOC)cccc1Oc1ncc(C(F)(F)F)cc1Cl)S(=O)(=O)N1CCCC(C(N)=O)C1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.41
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4603015 0.76 PPARG (0.45) PPARG
SCHEMBL4601910 0.76 PPARG (0.45) PPARG
SCHEMBL4603253 0.76 PPARG (0.47) PPARG
SCHEMBL4602114 0.76 PPARG (0.46) PPARG
SCHEMBL4602279 0.70 PPARG (0.56) PPARG
SCHEMBL4601368 0.70 PPARG (0.42) PPARG
SCHEMBL4601766 0.70 ALDH1A1 (0.51) PPARG
SCHEMBL4601372 0.70 PPARG (0.47) PPARG
SCHEMBL4600789 0.70 HPGD (0.48) PPARG
SCHEMBL3210963 0.67 PPARG (0.56) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed